captopril has been researched along with Metabolic Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morphy, R; Rankovic, Z | 1 |
Malacco, E; Omboni, S; Parati, G | 1 |
Hiroto, S; Ishikawa, Y; Kaneko, Y; Miyakawa, T; Shindo, Y; Shionoiri, H; Takasaki, I | 1 |
2 review(s) available for captopril and Metabolic Diseases
Article | Year |
---|---|
Designed multiple ligands. An emerging drug discovery paradigm.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors | 2005 |
Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Kidney Diseases; Metabolic Diseases | 2009 |
1 other study(ies) available for captopril and Metabolic Diseases
Article | Year |
---|---|
Glucose tolerance during chronic captopril therapy in patients with essential hypertension.
Topics: Adult; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Male; Metabolic Diseases; Middle Aged | 1987 |